PD29: Bladder Cancer: Epidemiology & Evaluation II

Sunday, April 30, 2023

9:30 AM – 11:30 AM CST

Location: S404A

CE: 1

Podium Session Moderator(s)

Edward Messing, MD, FACS

University of Rochester Medical Center
QL

Qiang Li, MD,PhD
HT

Hung-Jui Tan, MD

Presentations:

9:30 AM – 9:40 AM CST

PD29-01: The Hematuria Cancer Risk Score: A validation study demonstrating reduction in the number needed to investigate while preserving fidelity of cancer detection
Podium Presenter: Wei Shen Tan
9:40 AM – 9:50 AM CST

PD29-02: Benchmarking Bladder Cancer Care: A Real-life Population-based Study
Podium Presenter: Nicolas M. Vanin Moreno, MD,BS – Department of Urology, Queen's University
9:50 AM – 10:00 AM CST

PD29-03: Comparison of Reduced and Full BCG dosing in The Treatment of Non-Muscle Invasive Bladder Cancer
Podium Presenter: Andrew Salib, MD – Thomas Jefferson University Hospital
10:00 AM – 10:10 AM CST

PD29-04: PREDICTORS OF DEEP INCISIONAL AND ORGAN/SPACE SURGICAL SITE INFECTION FOLLOWING RADICAL CYSTECTOMY: RESULTS FROM THE ACS NSQIP SURGICAL REGISTRY
Podium Presenter: Ruben Blachman Braun, MD, MSC
10:10 AM – 10:20 AM CST

PD29-05: Association of Age With Non-Muscle Invasive Bladder Cancer: A Biological Basis For Epidemiological Disparities?
Podium Presenter: Niyati Lobo, MD
10:20 AM – 10:30 AM CST

PD29-06: Association Between Agent Orange Exposure and Risk of Bladder Cancer: A Nationwide Cohort Study
Podium Presenter: Stephen B. Williams, MD,MBA,MS – University of Texas Medical Branch
10:30 AM – 10:40 AM CST

PD29-07: Both EBRT and Brachytherapy Increase Probability of Subsequent Bladder Cancer Compared to Prostatectomy
Podium Presenter: Steven Monda, MD, MSCI
10:40 AM – 10:50 AM CST

PD29-08: Trans-urethral resection of the bladder (TURB) video consensus: a simple and effective way to improve awareness of patients undergoing TURB
Podium Presenter: Francesco Prata
10:50 AM – 11:00 AM CST

PD29-09: Comparison of Survival Outcomes Among Patients with Positive Soft Tissue Margins Versus Positive Non-Soft Tissue Margins Alone Following Radical Cystectomy for Muscle Invasive Bladder Cancer
Podium Presenter: Andrew Gabrielson, MD (he/him/his)
11:00 AM – 11:10 AM CST

PD29-10: Facility Level Variation in Pathologic Upstaging of Bladder Cancer after Radical Cystectomy
Podium Presenter: Madelyn Flitcroft
11:10 AM – 11:20 AM CST

PD29-11: Disparities in Stage at Diagnosis Among Black Bladder Cancer Patients in the Largest Equal Access Health System in the US: The Veterans Affairs Health System
Podium Presenter: Kelly Bree, MD
11:20 AM – 11:30 AM CST

PD29-12: Variations in Age of Bladder Cancer Onset Based on Germline Alterations
Podium Presenter: Peris Rose Castaneda, MD – Cedars Sinai Medical Center